S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

A. Görög, E. Antiga, M. Caproni, G. Cianchini, D. De, M. Dmochowski, J. Dolinsek, K. Drenovska, C. Feliciani, K. Hervonen, I. Lakos Jukic, Kinyó, T. Koltai, I. Korponay-Szabó, A. V. Marzano, A. Patsatsi, C. Rose, T. Salmi, E. Schmidt, J. SetterfieldM. Shahid, C. Sitaru, S. Uzun, F. Valitutti, S. Vassileva, S. Yayli, M. Sárdy*

*Corresponding author for this work

Abstract

Introduction: Dermatitis herpetiformis (DH) is a chronic, pruritic, gluten-induced skin disorder characterized by subepidermal granular IgA deposition and a variable degree of enteropathy identical to that seen in coeliac disease. So far, there has been no European consensus about the management of DH. Methods: The guidelines were created by small subgroups of a guideline committee consisting of 26 specialists from various medical fields and one patients’ representative. The members of the committee then discussed the guidelines and voted for the final version at two consensus meetings. The guidelines were developed under the support of the European Academy of Dermatology and Venereology (EADV) and in collaboration with the European Dermatology Forum (EDF). Results: The guidelines summarize evidence-based and expert-based recommendations (S2 level) for the management of DH (see Appendix). Conclusion: These guidelines will improve the quality of management of DH and support dermatologists in their diagnostic and therapeutic decisions.

Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology
Volume35
Issue number6
Pages (from-to)1251-1277
Number of pages27
ISSN0926-9959
DOIs
Publication statusPublished - 06.2021

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)'. Together they form a unique fingerprint.

Cite this